GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Inotiv Inc.
Inotiv is a contract research organization (CRO) that provides preclinical testing services. Its stock price reflects demand from biotech companies, but also animal welfare scandals that have damaged its reputation.
Share prices of companies in the market segment - Pharma tests
Inotiv is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotech companies. We've categorized it as "Pharma Testing." The chart below shows the dynamics of the pharmaceutical outsourcing sector.
Broad Market Index - GURU.Markets
Inotiv is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotech companies. It is a component of the GURU.Markets index. The chart below represents the market. See how its stock compares to the pharmaceutical services sector.
Change in the price of a company, segment, and market as a whole per day
NOTV - Daily change in the company's share price Inotiv Inc.
The daily price change of Inotiv, Inc. reflects volatility in the preclinical research sector. This indicator demonstrates sensitivity to R&D spending by biotech and pharmaceutical companies, providing an indicator of the state of the industry.
Daily change in the price of a set of shares in a market segment - Pharma tests
Inotiv, Inc. is a contract research organization (CRO). This chart shows the average daily volatility of the healthcare sector. Comparison with the dynamics of NOTV, whose revenue depends on pharmaceutical companies' R&D budgets, makes it a barometer of innovation.
Daily change in the price of a broad market stock, index - GURU.Markets
Inotiv provides preclinical research services to pharmaceutical companies. Its business serves as a barometer of R&D activity in the pharmaceutical industry. Its stock price is an indicator of innovation activity, which influences the overall market backdrop, as shown in the chart.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Inotiv Inc.
Inotiv, Inc.'s year-over-year performance tells the story of its role as a contract research organization (CRO). Its 12-month market cap reflects demand for its preclinical testing services from pharmaceutical and biotech companies, as well as its commitment to animal welfare.
Annual dynamics of market capitalization of the market segment - Pharma tests
Inotiv, Inc. is a contract research organization (CRO) providing preclinical drug development services. The chart illustrates how its business, dependent on pharmaceutical companies' R&D budgets, and its acquisition strategy impact its performance in the healthcare sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
As a contract research organization (CRO), Inotiv is a gold mine for biotech. Demand for its services is stable, as drug development continues. The company's stock performance demonstrates the resilience typical of companies providing scientific infrastructure.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Inotiv Inc.
Inotiv is a contract research organization (CRO) providing pharmaceutical development services. Its business depends on the level of R&D spending in the biotech sector. Monthly fluctuations in its value reflect the demand for its services and its operational efficiency.
Monthly dynamics of market capitalization of the market segment - Pharma tests
Inotiv is a contract research organization (CRO) that provides preclinical drug development services to pharmaceutical and biotech companies. The chart below illustrates the overall dynamics in the pharmaceutical testing and research sector, where outsourcing is the norm.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Inotiv, Inc. is a contract research organization (CRO) providing preclinical research services to pharmaceutical companies. Its business depends on the volume of R&D investments in the biotech sector. Its stock performance reflects the health of the biotech industry, which does not always align with the market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Inotiv Inc.
The short-term fluctuations of Inotiv, a contract research organization providing preclinical research services, reflect the state of the biotech sector. Biotech funding and R&D activity directly impact its order book.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Inotiv and the entire contract research organization (CRO) sector depend on the overall R&D budgets of the pharmaceutical industry. Growing investment in biotech is a driver for everyone. The chart shows how the company competes for share in this growing market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Inotiv and the entire contract research organization (CRO) sector depend on the overall R&D budgets of the pharmaceutical industry. Growing investment in biotech is a driver for everyone. The chart shows how the company competes for share in this growing market.
Market capitalization of the company, segment and market as a whole
NOTV - Market capitalization of the company Inotiv Inc.
The Inotiv market capitalization chart is a financial valuation of a contract research organization (CRO) providing preclinical research services to the pharmaceutical industry. It reflects both acquisition-led growth and recent operational challenges. Its dynamics tell a story about how investors assess the risks and prospects in this segment.
NOTV - Share of the company's market capitalization Inotiv Inc. within the market segment - Pharma tests
Inotiv is a contract research organization (CRO) that provides preclinical drug testing services and the production of animal research models. Its market share reflects its important role in the drug discovery ecosystem. The chart below shows the importance of this "pharma outsourcer."
Market capitalization of the market segment - Pharma tests
Inotiv is a contract research organization (CRO) providing preclinical research services. The chart below shows the total market capitalization of the entire pharmaceutical testing sector. Its growth reflects R&D outsourcing in the pharmaceutical industry. Inotiv is a vital link in the long chain of drug development.
Market capitalization of all companies included in a broad market index - GURU.Markets
Preclinical research, as shown in the chart, is a vital part of drug development. Inotiv, Inc. is a contract research organization (CRO) that conducts animal research for pharmaceutical companies. Its market capitalization reflects the demand for outsourcing these services.
Book value capitalization of the company, segment and market as a whole
NOTV - Book value capitalization of the company Inotiv Inc.
Inotiv's book value is the physical size of its contract research organization (CRO). The chart reflects the value of its numerous laboratories and animal facilities where preclinical drug trials are conducted for pharmaceutical companies.
NOTV - Share of the company's book capitalization Inotiv Inc. within the market segment - Pharma tests
Inotiv, Inc. is a contract research organization. Its stake in the sector is its numerous laboratories and animal facilities. This extensive physical infrastructure allows it to provide preclinical research and laboratory animal breeding services to the entire pharmaceutical industry.
Market segment balance sheet capitalization - Pharma tests
Inotiv, Inc. is a contract research organization. Its business is capital-intensive. Its balance sheet reflects the cost of its laboratories, animal facilities, and scientific equipment. Compared to the pharmaceutical sector, it is a "heavy" service company providing R&D infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Inotiv's assets aren't drugs, but a network of laboratories providing preclinical research services to pharmaceutical companies. The company's balance sheet consists of its scientific equipment and animal models. The chart shows the capital behind this "outsourced" science, which helps create new drugs.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Inotiv Inc.
Inotiv is a contract research organization providing preclinical drug testing services. Its market capitalization reflects the demand for R&D outsourcing from pharmaceutical companies, but also the risks associated with animal testing.
Market to book capitalization ratio in a market segment - Pharma tests
Inotiv provides preclinical research services to pharmaceutical companies and also sells laboratory animals. It's a service business that's essential to medical R&D. This chart shows how the market views its role in this ecosystem.
Market to book capitalization ratio for the market as a whole
Inotiv provides preclinical research services to pharmaceutical companies. Its business is based on laboratory ownership and strong scientific expertise. The chart shows the market valuation of this service company, which is a vital part of the drug development process, combining tangible assets with scientific capital.
Debts of the company, segment and market as a whole
NOTV - Company debts Inotiv Inc.
Inotiv provides preclinical research services to the pharmaceutical industry. The company often grows through the acquisition of other research laboratories. Debt financing is a key tool for implementing this consolidation strategy and expanding the range of services offered.
Market segment debts - Pharma tests
Inotiv, Inc. is a contract research organization (CRO) providing preclinical research services to pharmaceutical companies. Growth in this sector often occurs through acquisitions. This chart shows how Inotiv is using debt financing to acquire other CROs and expand its services to the biotech and pharmaceutical industries.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Inotiv Inc.
Inotiv, Inc. provides preclinical research services to pharmaceutical companies. This chart shows its debt load. The business depends on the size of R&D budgets in the biotech industry. A funding cut in the sector could lead to a decline in orders, making it difficult to service the debt taken on for laboratory expansion.
Market segment debt to market segment book capitalization - Pharma tests
Inotiv is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotech companies. This chart compares the company's debt to the overall market capitalization of the sector. It helps assess how the company is funding the expansion of its laboratories and services.
Debt to book value of all companies in the market
Inotiv, Inc. provides preclinical research services to pharmaceutical and biotech companies. Growth in this sector could be achieved through acquisitions of other laboratories. The chart shows how the company uses debt capital for its M&A strategy, which compares favorably with other players in the contract research market.
P/E of the company, segment and market as a whole
P/E - Inotiv Inc.
This chart for Inotiv, a preclinical research organization for pharmaceutical companies, is a barometer of R&D activity. Investor profit estimates depend on drug development budgets. The trend reflects how actively biotech and pharmaceutical companies outsource research.
P/E of the market segment - Pharma tests
This chart shows the average valuation for the pharmaceutical services (CRO) sector—the benchmark for Inotiv. Comparing this metric helps investors understand how the market perceives the company's reputational risks and its reliance on preclinical research budgets, which can shrink during downturns.
P/E of the market as a whole
Inotiv is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotech companies. Its business depends on the volume of R&D in the pharmaceutical industry. This chart reflects sentiment in the biotech sector. It helps us understand whether Inotiv is a barometer of research activity in the industry and how mergers and acquisitions are impacting its growth.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Inotiv Inc.
Inotiv provides preclinical research services for pharmaceutical and biotech companies and breeds laboratory animals. Its future profits depend on R&D spending in the pharmaceutical industry. This chart shows analysts' estimates of activity in this sector and demand for preclinical testing outsourcing.
%20P%2FE%20Inotiv%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Inotiv-Inc.&v=1772634995754 "Chart of the company's future (projected) P/E Inotiv Inc.")
Future (projected) P/E of the market segment - Pharma tests
Inotiv is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotech companies. The chart shows how the company's revenue forecasts compare to the industry average. This reflects the market's perception of its role in the drug development process and its acquisition-led growth strategy.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-tests&v=1772634995777 "Future (projected) P/E graph of the market segment - Pharma tests")
Future (projected) P/E of the market as a whole
Inotiv provides preclinical research services to pharmaceutical companies. This chart shows the overall sentiment. Inotiv's business is relatively stable, as R&D spending in the pharmaceutical industry is planned years in advance. Demand for their services depends on the flow of biotech innovation, not short-term economic cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772634995824 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Inotiv Inc.
Inotiv is a contract research organization (CRO) that provides preclinical drug development services to pharmaceutical and biotech companies. This chart shows financial results based on R&D outsourcing volumes in the pharmaceutical industry.
Profit of companies in the market segment - Pharma tests
Inotiv is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotech companies. It helps test the safety and efficacy of new drugs. This chart shows the financial climate in the pharmaceutical testing sector, which depends on the size of R&D budgets across the pharmaceutical industry.
Overall market profit
Inotiv provides preclinical research services for pharmaceutical companies and also produces laboratory animals. Demand for its services depends on the size of R&D budgets in the pharmaceutical industry. These budgets are generally stable and less susceptible to short-term economic fluctuations than other industries.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Inotiv Inc.
Inotiv provides preclinical research services to pharmaceutical and biotech companies. Its business depends on investment in drug development. This chart reflects analyst expectations for R&D activity in the global pharmaceutical industry.
%20profit%20of%20the%20company%20Inotiv%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Inotiv-Inc.&v=1772634995904 "Graph of future (projected) profit of the company Inotiv Inc.")
Future (predicted) profit of companies in the market segment - Pharma tests
Inotiv, Inc. is a contract research organization (CRO) that provides preclinical drug development services, including animal studies. This chart shows forecasts for the pharmaceutical services sector. Inotiv's profitability depends on the volume of research outsourcing from biotech and pharmaceutical companies.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-tests&v=1772634995952 "Graph of future (predicted) profits of companies in a market segment - Pharma tests")
Future (predicted) profit of the market as a whole
Inotiv, Inc. provides preclinical research services to pharmaceutical and biotech companies. Demand for its services is directly related to the level of R&D funding in the industry. This graph, reflecting revenue expectations, is an indicator of the health of the biotech sector and its ability to attract capital for new developments.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772634995970 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Inotiv Inc.
Inotiv is a contract research organization (CRO) providing preclinical drug development services to pharmaceutical companies. This chart shows how investors value its revenue. It reflects the demand for R&D outsourcing in the pharmaceutical industry and the success of its acquisition-based growth strategy.
P/S market segment - Pharma tests
Inotiv is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotech companies. Its revenue is driven by R&D spending in the pharmaceutical industry. This chart shows the average valuation in the sector, helping to understand how the market values Inotiv's role in the drug development process.
P/S of the market as a whole
Inotiv is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotech companies. Inotiv's revenue is driven by R&D activity in the pharmaceutical industry. This chart helps assess the market's perception of revenue for this important outsourcing partner for the entire healthcare industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Inotiv Inc.
Inotiv provides preclinical research services to pharmaceutical and biotech companies. This chart shows how investors estimate the company's future revenue. It is closely linked to the level of investment in drug development in the industry, as this directly impacts demand for outsourced research services.
%20P%2FS%20Inotiv%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Inotiv-Inc.&v=1772634996067 "The graph of the company's future (projected) P/S Inotiv Inc.")
Future (projected) P/S of the market segment - Pharma tests
Inotiv is a contract research organization (CRO) providing preclinical research services to pharmaceutical companies. This chart compares the company's estimated future sales with its industry. It reflects the market's assessment of Inotiv's R&D outsourcing volumes and competitive position.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20tests&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-tests&v=1772634996094 "Future (projected) P/S market segment graph - Pharma tests")
Future (projected) P/S of the market as a whole
Inotiv provides preclinical research services to pharmaceutical and biotech companies. The optimism this indicator demonstrates is often fueled by medical innovation. Inotiv's activity is a leading indicator of the health of the entire biopharmaceutical industry, as its services are essential for the development of new drugs.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772634996117 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Inotiv Inc.
Inotiv is a contract research organization (CRO) providing preclinical drug development services. Revenue, shown in this chart, is generated by fulfilling orders from pharmaceutical and biotech companies to conduct animal studies to evaluate the safety and efficacy of new drugs.
Sales of companies in the market segment - Pharma tests
Inotiv is a contract research organization (CRO) that provides preclinical drug development services to pharmaceutical and biotech companies. This chart illustrates the state of the pharmaceutical industry, where research outsourcing, like Inotiv's, is standard practice for accelerating development.
Overall market sales
Inotiv, Inc. is a contract research organization (CRO) providing preclinical drug development services. Its business depends on activity in the pharmaceutical and biotech industries. Growth in total revenue, as reflected in this chart, often correlates with increased R&D investment, which directly increases demand for Inotiv's outsourcing services.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Inotiv Inc.
Inotiv, Inc. is a contract research organization (CRO) that provides preclinical research services to pharmaceutical and biotechnology companies. This chart reflects analyst expectations for R&D spending in the pharmaceutical industry, which drives demand for Inotiv's services.
%20sales%20of%20the%20company%20Inotiv%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Inotiv-Inc.&v=1772634996266 "Schedule of future (projected) sales of the company Inotiv Inc.")
Future (projected) sales of companies in the market segment - Pharma tests
Inotiv provides preclinical research services for pharmaceutical and biotech companies and produces laboratory animals. This chart shows forecasts for the pharmaceutical testing sector. It illustrates the importance of research outsourcing for accelerating drug development, which is the core of Inotiv's business.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-tests&v=1772634996310 "Schedule of future (projected) sales of companies in the market segment - Pharma tests")
Future (projected) sales of the market as a whole
Inotiv, a contract research organization, sees this chart as an indicator of investment activity in the pharmaceutical and biotech industries. Economic growth, reflected here, encourages companies to invest more in preclinical and clinical trials of new drugs, which directly increases demand for Inotiv's services.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772634996332 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Inotiv Inc.
Inotiv is a contract research organization (CRO) that provides preclinical drug development services to pharmaceutical companies. Its profitability depends on the flow of orders from biotech and pharmaceutical clients. This chart shows how effectively the company manages its labs and projects to generate profit.
Market segment marginality - Pharma tests
Inotiv is a contract research organization (CRO) providing preclinical drug development services to pharmaceutical companies. Profitability in this business depends on the efficiency of research, laboratory management, and attracting clients from the biotech sector.
Market marginality as a whole
Inotiv provides preclinical research services to pharmaceutical and biotech companies. This chart shows profitability, and Inotiv is part of the infrastructure for developing new drugs. Their profitability depends on the level of R&D investment in the pharmaceutical industry and the demand for research outsourcing.
Employees in the company, segment and market as a whole
Number of employees in the company Inotiv Inc.
Inotiv is a contract research organization (CRO) providing preclinical drug development services. This chart shows its large team of scientists and technicians. The growth reflects the demand from pharmaceutical companies for outsourced R&D.
Share of the company's employees Inotiv Inc. within the market segment - Pharma tests
Inotiv is a contract research organization (CRO) providing preclinical research services to pharmaceutical and biotech companies. This chart shows the significant share of scientists and lab technicians in the pharmaceutical testing sector that Inotiv employs, reflecting its scale and critical role in the drug development process.
Number of employees in the market segment - Pharma tests
Inotiv is a contract research organization (CRO) providing preclinical drug development services. Its business requires a large team of scientists, veterinarians, and technicians. This chart shows how the company is growing due to demand from the pharmaceutical industry. This growth is driven by capacity expansion and acquisitions of other CROs.
Number of employees in the market as a whole
Inotiv provides preclinical research services to pharmaceutical companies. Its business depends on the volume of R&D investment in the biotech sector. This metric may not directly correlate with the overall employment reflected in the graph, as medical innovation continues to be funded even during recessions.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Inotiv Inc. (NOTV)
Inotiv is a contract research organization. It's a service business based on the labor of scientists. This figure would be moderate, reflecting that value is created by the expertise of a large number of specialists, not by scalable technology.
%20of%20the%20company%20Inotiv%20Inc.%20(NOTV)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Inotiv-Inc.-NOTV&v=1772634996439 "Chart of market capitalization per employee (in thousands of dollars) of the company Inotiv Inc. (NOTV)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Inotiv, Inc. is a contract research organization (CRO) providing preclinical drug development services. The company's value lies in its expertise, equipment, and ability to support pharmaceutical companies. This metric reflects how the market perceives the quality of its services and its contribution to the development of new drugs.
%20by%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-tests&v=1772634996463 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma tests")
Market capitalization per employee (in thousands of dollars) for the overall market
Inotiv provides preclinical research services for pharmaceutical and biotech companies. It is a contract research organization (CRO). The chart shows how the market values this service business, where key assets include scientific expertise, laboratory capacity, and customer trust.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772634996472 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Inotiv Inc. (NOTV)
Inotiv (NOTV) is a contract research organization (CRO). They conduct preclinical (animal) studies for biotech and pharmaceutical companies. This is a labor-intensive scientific service. This chart shows how efficiently the company manages its labs and scientists, generating revenue from each contract.
%20Chart%20Inotiv%20Inc.%20(NOTV)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Inotiv-Inc.-NOTV&v=1772634996527 "Company Profit Per Employee (in thousands of dollars) Chart Inotiv Inc. (NOTV)")
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Inotiv (NOTV) is a contract research organization (CRO) providing preclinical research services (including animal testing) and research model production. In the R&D services industry, this metric reflects laboratory efficiency. It shows how much revenue the company generates from each scientist and laboratory technician performing research for pharmaceutical companies.
%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-tests&v=1772634996551 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma tests")
Profit per employee (in thousands of dollars) for the market as a whole
Inotiv is a contract research organization (CRO). It conducts preclinical studies (including animal studies) for biotech and pharmaceutical companies. It's a knowledge-intensive service business. This chart shows how efficiently Inotiv utilizes its scientists and laboratories. Revenue per employee depends on capacity utilization and contract value.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772634996572 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Inotiv Inc. (NOTV)
Inotiv is a contract research organization (CRO) providing preclinical research services to pharmaceutical companies. This chart is a direct indicator of the effectiveness of their service business. It measures the revenue generated by each scientist and technician from conducting research for clients.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Inotiv-Inc.-NOTV&v=1772634996607 "Sales chart per company employee Inotiv Inc. (NOTV)")
Sales per employee in the market segment - Pharma tests
Inotiv is a contract research organization (CRO) providing preclinical research services (animal testing) to pharmaceutical companies. This chart shows the average revenue per employee in the sector. In the R&D services business, it demonstrates how productive Inotiv's laboratories and scientific staff are compared to other CROs.
Sales per employee for the market as a whole
Inotiv, Inc. (NOTV) is a contract research organization (CRO). They provide services (preclinical research, animal testing) to pharmaceutical and biotech companies, helping them develop new drugs. This chart shows the revenue generated by each of their scientists and technicians.
Short shares by company, segment and market as a whole
Shares shorted by company Inotiv Inc. (NOTV)
Inotiv is a contract research organization (CRO) that conducts preclinical trials (including animal trials) for biotech companies. The company has encountered problems. The chart shows the number of investors betting that animal supply scandals and facility closures will damage its reputation and lead to customer losses.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Inotiv-Inc.-NOTV&v=1772634996857 "Short Shares Chart for the Company Inotiv Inc. (NOTV)")
Shares shorted by market segment - Pharma tests
Inotiv is a contract research organization (CRO) that conducts preclinical drug trials for pharmaceutical companies. This indicator aggregates bets against the entire sector. Its rise indicates that investors expect a slowdown in biotech R&D budgets, leading to a decline in orders for all CROs.
Shares shorted by the overall market
Inotiv (NOTV) is a contract research organization (CRO) that tests drugs for biotechs. Its business is a "shovel" for R&D. When this chart shows rising fear, it signals a "venture winter." This means NOTV's clients (small biotechs) are freezing R&D.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Inotiv Inc. (NOTV)
Inotiv is a contract research organization (CRO) that helps biotechs conduct preclinical trials. Their success depends on the overall R&D budgets of the pharmaceutical industry. This indicator tracks how investors evaluate this order flow, showing "overheated" (above 70) at the peak of biotech funding or "oversold" (below 30) during the downturn.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Inotiv-Inc.-NOTV&v=1772634996953 "RSI 14 indicator chart for the company's stock Inotiv Inc. (NOTV)")
RSI 14 Market Segment - Pharma tests
Inotiv is a contract research organization (CRO) providing preclinical drug development services, including animal studies and analytical services. This chart reflects the overall health of the CRO sector and helps understand whether the entire segment is oversold amid changes in biotech R&D budgets.
RSI 14 for the overall market
Inotiv is a "service" (CRO) for biotechs, conducting research for them. This chart is an indicator of R&D budgets. In the euphoria of funding, biotechs are generously funded by investors and immediately hire Inotiv for R&D. In a panic, the funding for biotechs is shut off, and contracts for "auxiliary" research are cut.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NOTV (Inotiv Inc.)
Inotiv is a contract research organization (CRO). They provide preclinical research services (animal testing) for biotech and pharmaceutical companies. This chart shows the average 12-month forecast from analysts. It reflects their view on biotech R&D budgets and the company's reputational risks.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NOTV-Inotiv-Inc.&v=1772634997031 "A chart showing analyst consensus forecasts for the expected stock price. NOTV (Inotiv Inc.)")
The difference between the consensus estimate and the actual stock price NOTV (Inotiv Inc.)
Inotiv is a contract research organization (CRO). It provides preclinical (animal) testing services for biotech and pharmaceutical companies. This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their view on R&D outsourcing.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NOTV-Inotiv-Inc.&v=1772634997065 "A chart showing the difference between the consensus forecast and the actual stock price. NOTV (Inotiv Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma tests
Inotiv is a contract research organization (CRO) that conducts pre-clinical (animal) research for biotech companies. It's an R&D outsourcing service. This chart shows analysts' overall expectations for the entire pharma testing sector. It reflects whether experts believe R&D budgets in biotech will grow or decline.
Analysts' consensus forecast for the overall market share price
Inotiv (NOTV) is a contract research organization (CRO) that provides preclinical research services (animal testing) for biotechs and pharmaceutical companies. This chart shows overall market sentiment. For Inotiv, whose business operates behind the scenes in the defensive pharmaceutical sector, the overall optimism is important because it reflects the risk appetite and funding of its biotech clients.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Inotiv Inc.
Inotiv (NOTV) is an on-call lab. It's a contract research organization (CRO) that provides services to biotech companies, from preclinical animal testing to analytical services. This chart is a barometer of R&D outsourcing. It reflects their ability to win contracts from biotech companies, but also their operational challenges and high debt load.
AKIMA Market Segment Index - Pharma tests
Inotiv (NOTV) is a contract research organization (CRO) that provides preclinical drug development services, including animal testing and analytical services, to pharmaceutical companies. The chart shows the average index for the segment, helping investors assess how Inotiv, as a pharma outsourcer, compares to the sector average.
The AKIM Index for the overall market
Inotiv is a contract research organization (CRO) specializing in preclinical research and animal models. This chart, reflecting the market average, provides context. It helps assess how Inotiv, a critical partner for pharma but facing operational challenges, compares to overall macroeconomic trends.
